WENTWORTH KORY JAMES 4
4 · Entrada Therapeutics, Inc. · Filed Apr 4, 2025
Insider Transaction Report
Form 4
WENTWORTH KORY JAMES
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-04-03$2.10/sh+11,134$23,381→ 120,670 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-04-03−11,134→ 20,023 totalExercise: $2.10Exp: 2030-11-10→ Common Stock (11,134 underlying)
Footnotes (1)
- [F1]The shares subject to this option fully vested on November 16, 2024.